2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow AZD2014: new trials by email Literature Review of AZD2014 trials Research Report on AZD2014
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) AZD2014, Anastrozole - Endometrial Carcinoma, Metastatic Carcinoma | Phase 1 / Phase 2 | Unknown | Centre Leon Berard | 72 | 2016-04-01 | 2024-02-13 |
| A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers AZD2014, AZD6244 - Triple-Negative Breast Cancer, Squamous Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | Queen Mary University of London | 118 | 2015-06-01 | 2020-02-25 |
Carcinoma (1) · Endometrial Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Centre Leon Berard (1) · Queen Mary University of London (1)
France (1) · United Kingdom (1)
2014 (1)